California

FDA Announces Investigation of Brain Infection Associated with Novartis Drug Gilenya

On August 29, 2013, the FDA issued a drug safety alert after a European patient developed a rare and serious brain infection—progressive multifocal leukoencephalopathy (PML)—after taking the drug Gilenya (fingolimod).…

Read more

Park Pharmacy & Compounding Center Issues Recall Due to Sterility Concerns

On August 27, 2013, the FDA issued a trio of recall alerts regarding compounded drugs. In one of the safety alerts, the FDA announced the voluntary recall of two lots…

Read more